Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,268
Closed -$633K 111
2025
Q2
$633K Sell
2,268
-1,073
-32% -$304K 0.01% 144
2025
Q1
$1.04M Buy
+3,341
New +$987K 0.02% 90
2024
Q4
Sell
-1,225
Closed -$395K 346
2024
Q3
$395K Buy
+1,225
New +$401K 0.01% 116

Other funds holding AMGN

Iconiq Capital's AMGN Position: Q3 2025 in Review

Iconiq Capital sold out of Amgen (AMGN) in Q3 2025, closing a stake of 2,268 shares — an estimated $633K sold.

Iconiq Capital first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $1.04M in Q1 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Iconiq Capital reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Iconiq Capital sold 2,268 Amgen shares in Q3 2025, an estimated $633K.
  • Iconiq Capital first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
  • Iconiq Capital's Amgen position peaked at $1.04M in Q1 2025.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Iconiq Capital's 13F filing for Q3 2025, filed 14 Nov 2025.